CH642542A5 - Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum. - Google Patents

Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum. Download PDF

Info

Publication number
CH642542A5
CH642542A5 CH1273778A CH1273778A CH642542A5 CH 642542 A5 CH642542 A5 CH 642542A5 CH 1273778 A CH1273778 A CH 1273778A CH 1273778 A CH1273778 A CH 1273778A CH 642542 A5 CH642542 A5 CH 642542A5
Authority
CH
Switzerland
Prior art keywords
hydrogen atom
diuretic
composition according
proline
group
Prior art date
Application number
CH1273778A
Other languages
German (de)
English (en)
Inventor
Zola Phillip Horovitz
Bernard Rubin
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH642542(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CH642542A5 publication Critical patent/CH642542A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH1273778A 1977-12-27 1978-12-14 Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum. CH642542A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27

Publications (1)

Publication Number Publication Date
CH642542A5 true CH642542A5 (de) 1984-04-30

Family

ID=25343256

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1273778A CH642542A5 (de) 1977-12-27 1978-12-14 Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum.

Country Status (30)

Country Link
JP (1) JPS54110333A (sv)
AR (1) AR230378A1 (sv)
AU (1) AU526239B2 (sv)
BE (1) BE873092A (sv)
CA (1) CA1120400A (sv)
CH (1) CH642542A5 (sv)
DE (1) DE2854316C3 (sv)
DK (1) DK578778A (sv)
EG (1) EG14178A (sv)
FI (1) FI783991A (sv)
FR (1) FR2413089A1 (sv)
GB (1) GB2010675B (sv)
GR (1) GR72951B (sv)
HK (1) HK45483A (sv)
HU (1) HU178747B (sv)
IE (1) IE48306B1 (sv)
IL (1) IL56281A (sv)
IT (1) IT1202811B (sv)
KE (1) KE3235A (sv)
LU (1) LU80709A1 (sv)
MY (2) MY8300240A (sv)
NL (2) NL192870C (sv)
NO (1) NO784357L (sv)
NZ (1) NZ189159A (sv)
PH (1) PH22111A (sv)
PL (1) PL212188A1 (sv)
PT (1) PT68983A (sv)
SE (1) SE445173B (sv)
SG (1) SG41482G (sv)
ZA (1) ZA786948B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PH22111A (en) 1988-06-01
NZ189159A (en) 1984-12-14
AU526239B2 (en) 1982-12-23
IE782413L (en) 1979-06-27
PT68983A (en) 1979-01-01
LU80709A1 (de) 1979-04-13
IT7831266A0 (it) 1978-12-22
MY8300240A (en) 1983-12-31
CA1120400A (en) 1982-03-23
IL56281A0 (en) 1979-03-12
NL192870B (nl) 1997-12-01
JPS54110333A (en) 1979-08-29
KE3235A (en) 1982-11-05
DK578778A (da) 1979-06-28
EG14178A (en) 1984-06-30
GB2010675A (en) 1979-07-04
NL980017I1 (nl) 1998-07-01
JPS647045B2 (sv) 1989-02-07
HK45483A (en) 1983-10-28
IE48306B1 (en) 1984-12-12
SE445173B (sv) 1986-06-09
SE7813277L (sv) 1979-06-28
ZA786948B (en) 1980-04-30
NL7812164A (nl) 1979-06-29
FR2413089A1 (fr) 1979-07-27
MY102991A (en) 1993-03-31
IL56281A (en) 1983-05-15
SG41482G (en) 1985-01-11
GR72951B (sv) 1984-01-17
AR230378A1 (es) 1984-04-30
DE2854316C2 (sv) 1989-08-10
DE2854316C3 (de) 1994-12-22
BE873092A (fr) 1979-06-27
IT1202811B (it) 1989-02-09
AU4204178A (en) 1979-07-05
PL212188A1 (sv) 1980-02-11
HU178747B (en) 1982-06-28
DE2854316A1 (de) 1979-07-05
FR2413089B1 (sv) 1980-12-26
FI783991A (fi) 1979-06-28
NO784357L (no) 1979-06-28
GB2010675B (en) 1982-06-16
NL192870C (nl) 1998-04-02

Similar Documents

Publication Publication Date Title
EP0351885B1 (de) Verwendung von Pentoxifyllin zur Behandlung entzündlicher Erkrankungen
CH659948A5 (de) Mittel zur verstaerkung der antitumor-wirksamkeit von mitomycin-c und doxorubicin-hydrochlorid.
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE2462367A1 (de) 7-(oxoalkyl)-1,3-dialkylxanthine enthaltende arzneimittelzubereitungen
DE2854316C2 (sv)
DE3511609C2 (sv)
DE3212736A1 (de) Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE1767163C3 (de) Blutdrucksenkendes Arzneimittel
DE2625012C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2403122C2 (sv)
DE2642879C3 (de) 4-Aroyl-2,3-Dichlorphenoxyessigsäuren und diese enthaltende Arzneimittel
DE2350222A1 (de) Pharmazeutische mittel, die ein 4-aryl-2-(3-pyridyl)-thiazol enthalten, und ihre anwendung
DD201797A5 (de) Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion
DE2805224B2 (de) Verfahren zum Herstellen der aktiven Substanz eines Arzneimittels zur Behandlung von Nierensteinleiden sowie ein diese aktive Substanz enthaltendes Arzneimittel
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
EP0471388A2 (de) Mittel zur Behandlung der Herzinsuffizienz
DE69912375T2 (de) Adenosin a1 rezeptor antagonisten enthaltende zusammensetzung und verfahren zur wiederherstellung der diuretischen- und nierenfunktion
DE2755017C2 (sv)
EP0032564A1 (de) Pharmazeutische Verwendung von Caroverin und/oder Caroverinsalzen sowie Caroverinsalze mit Xanthinderivat-Säureresten und Nicotinsäurerest
EP0116944A1 (de) Glycerinmononitrate zur Behandlung der Angina pectoris
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
EP0301373A2 (de) Erzeugnisse, enthaltend Gallopamil und Prazosin
DE2636328A1 (de) Arzneimittel
DE2951669C2 (de) Arzneimittel
DE2532180C2 (de) Verwendung von Etozolin bei der Bekämpfung der Hypertonie

Legal Events

Date Code Title Description
SPCF Supplementary protection certificate filed

Free format text: IKS 46667, 950927

SPCG Supplementary protection certificate granted

Free format text: IKS 46667/841218, 950927, EXPIRES:19991218

PL Patent ceased